Filter by: patients
Home > Community Treatment Reports and Side Effects > Abacavir-lamivudine-zidovudine Treatment Report
What is Abacavir-lamivudine-zidovudine?

Abacavir-lamivudine-zidovudine is the combination of three nucleoside reverse transcriptase inhibitor (NRTI) drugs. NRTIs block reverse transcriptase, a protein that HIV needs to make more copies of itself.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 30 9 Efficacy_major Efficacy_moderate Efficacy_cant_tell
General health 1 0
Other 1 0

See all 24 patients currently taking Abacavir-lamivudine-zidovudine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 4
Moderate
 1
Mild
 3
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Abacavir-lamivudine-zidovudine

Abdominal pain 3
Nausea 3
Stomach pain 3
Diarrhea 2
Anemia 2
Major Depressive Disorder 1
See all 8 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

  daily 2 daily 2 tbs. daily 300 mg-150 mg-300 mg every other week 300 mg-150 mg-300 mg daily 300 mg daily 2 x 300 mg-150 mg-300 mg daily 750 mg daily 800 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 3 Number of Patients: 3 10 Number of Patients: 10 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Abacavir-lamivudine-zidovudine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 5   Doctor's advice: 31%
Did not seem to work 5   Did not seem to work: 31%
Other 3   Other: 19%
Expense 3   Expense: 19%
Personal research 2   Personal research: 13%
Side effects too severe 2   Side effects too severe: 13%
Course of treatment ended 1   Course of treatment ended: 6%

See all 15 patients who’ve stopped taking Abacavir-lamivudine-zidovudine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Abacavir-lamivudine-zidovudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Abacavir-lamivudine-zidovudine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Abacavir-lamivudine-zidovudine

Always
 5 56%
Usually
 3 33%
Sometimes
 1 11%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Abacavir-lamivudine-zidovudine

Very
 2 22%
Somewhat
 0 0%
A little
 4 44%
Not at all
 3 33%

Cost

Paid out of pocket

Cost of Abacavir-lamivudine-zidovudine

$200+
 0 0%
$100-199
 1 25%
$50-99
 2 50%
$25-49
 0 0%
< $25
 1 25%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.